Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
Public ClinicalTrials.gov record NCT01052688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Noninvasive Screening for Fetal Chromosomal Aneuploidy and Abnormality: Assay Development & Optimization in Affected Pregnancies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To collect samples for the purpose of developing and optimizing an in vitro noninvasive prenatal diagnostic (NIPD) test. The NIPD test employs circulating cell free (ccff) DNA extracted from whole blood samples collected from women who are pregnant with a fetus previously determined to have a chromosomal abnormality. The NIPD result will be compared to the standard test results obtained from other test methods such as karyotype, FISH, QF-PCR, and/or any commercially available NIPD test.
Study identification
- NCT ID
- NCT01052688
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2009 (Type not available)
- Primary completion
- Aug 31, 2021 (Actual)
- Completion
- Aug 31, 2021 (Actual)
- Last update posted
- Sep 20, 2021
2009 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Perinatal Care Associates | Phoenix | Arizona | 85013 | — |
| St. Joseph's Hospital and medical Center | Phoenix | Arizona | 85013 | — |
| Sharp Grossmount | San Diego | California | 91944 | — |
| IGO | San Diego | California | 92121 | — |
| San Diego Perinatal Center | San Diego | California | 92123 | — |
| Women's Healthcare at Frost Street | San Diego | California | 92123 | — |
| Reiter, Hill, Johnson and Nevin | Washington D.C. | District of Columbia | 20036 | — |
| Fetal Diagnostic Institute of the Pacific | Honolulu | Hawaii | 96814 | — |
| Spectrum Health | Grand Rapids | Michigan | 49503 | — |
| Women and Infants Hospital of Rhode Island | Providence | Rhode Island | 02902-2499 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01052688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01052688 live on ClinicalTrials.gov.